
---
title: '呼吸道合胞病毒疫苗和单抗最新研究进展（12）'
categories: 
 - 新媒体
 - 科学网
 - 博客
headimg: 'https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=956043'
author: 科学网
comments: false
date: Sat, 03 Sep 2022 08:54:00 GMT
thumbnail: 'https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=956043'
---

<div>   
<h1 style="margin-top:0;margin-right:0;margin-bottom:0;margin-left:0;padding:0 0 0 0 "><strong style="font-size: 16px;"><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 36px">呼吸道合胞病毒预防制剂曙光在前</span></strong><strong style="font-size: 16px;"><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 36px">:　</span></strong></h1><p style="margin-top:30px;margin-right:0;margin-bottom:54px;margin-left:0;padding:0 0 0 0 "><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 36px;background: #FFFFFF"><span style="font-family:Shaker2Lancet-Bold">疫苗和单克隆抗体百舸争流</span></span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">前言：</span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">　　新冠病毒大流行的将近３年，也是世界疫苗行业突飞猛进、疫苗研发技术日新月异、硕果累累的３年。疫苗制备的多种技术途径都得到深度开发，若干种新兴的技术途径如</span><span style="font-family:Microsoft YaHei UI">mRNA疫苗获得了空前的成功，在世界各地大行其道，在多种传染病以及癌症和其他慢性病的防治领域都在不断开花结果。</span></span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong>　　</strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px">呼吸道合胞病毒（</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 24px">Respiratory syncytial virus</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 24px"><span style="font-family:Shaker2Lancet-Bold">，</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px">RSV</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 24px"><span style="font-family:Shaker2Lancet-Bold">）</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">是一种历史悠久、危害极大的传染病，其疫苗的研发已经有四十年的历史，</span><span style="font-family:Microsoft YaHei UI"> 但最初开发的疫苗反而会引发</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">疫苗相关性呼吸道疾病（</span><span style="font-family:Microsoft YaHei UI">VAERD，Vaccine-associated enhanced respiratory diseases</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px">）</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">，即未接触过</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px">RSV</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">的儿童在接种了疫苗后，如果再接触到该病毒反而会发生更严重的</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px">RSV</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">疾病。诸如此类的问题导致针对</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px">RSV</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">的疫苗一直未能上市。乘新冠病毒疫苗大跃进的东风，已赚得盆满钵满的疫苗巨头如</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">辉瑞（</span><span style="font-family:Microsoft YaHei UI">Pfizer)</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">、</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">莫德纳（</span><span style="font-family:Microsoft YaHei UI">Moderna</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">）和</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px"><span style="font-family:Microsoft YaHei UI">葛兰素史克</span><span style="font-family:Microsoft YaHei UI">(GSK)</span></span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">等目前都在</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px">RSV</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">的疫苗开发上快马加鞭，有望在较短时间内取得重大突破。</span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong>　　</strong><strong><span style="text-decoration:underline;"><span style="font-family: 'Microsoft YaHei UI';letter-spacing: 0;font-size: 24px">RSV</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">疫苗和单克隆抗体研究领域来自世界各地的顶级研究人员（约５０人）近期联名在国际著名专业杂志《</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #FF0000;letter-spacing: 0;font-size: 24px">Lancet</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px"> Infect Dis》上发表综述论文，介绍相关最新研究进展（见</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #222222;letter-spacing: 0;font-size: 24px">参考文献</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">），本博客将分数次介绍此综述的主要内容。</span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 24px">目录：</span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px">摘要</span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">一</span>.　</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px">前言</span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">二</span>.　</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px">方法</span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">三</span>.　</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">教训（</span>Lessons learned）</span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">四</span>.　</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">减毒活疫苗（</span>live attenuated vaccines，LAVs ）</span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">五</span>.　</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">嵌合疫苗（</span>Chimeric ）</span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">六</span>.　</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">亚单位疫苗（</span>Subunit）</span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">七</span>.　</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">基于颗粒的疫苗（</span>Particle-based ）</span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">八</span>.　</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">核酸疫苗（</span>Nucleic acid）</span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">九</span>.　</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">重组载体疫苗（</span>Recombinant vectors）</span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">十</span>.　</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">单克隆抗体（</span>MAbs）</span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 21px"><span style="font-family:Shaker2Lancet-Bold">十一</span>.　讨论　</span></strong></p><p style="margin: 0 0 24px;text-indent: 0;padding: 0;background: rgb(255, 255, 255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #006F3C;letter-spacing: 0;font-size: 29px"><span style="font-family:Shaker2Lancet-Bold">九</span>.　重组载体疫苗（Recombinant vectors）</span></strong></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro">重组载体疫苗</span></span></span></strong><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">使用</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">经</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">改</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">造</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">的</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">复制缺陷</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px"><span style="font-family:ScalaLancetPro">病毒，通过传递</span>RSV抗原的基因来诱导体液和细胞免疫。有三种候选</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">疫苗</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">正在临床开发中，</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">分别</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">用于儿</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">童</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">和老年人群。</span></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">第一种</span><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro;line-height: 200%;color: #FF0000;font-size: 21px"><span style="font-family:ScalaLancetPro">重组载体疫苗</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro;line-height: 200%;color: #FF0000;font-size: 21px">MVA-BN-RSV</span></span></strong><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">使用</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">一种</span><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro">痘病毒载体</span></span></span></strong><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">，</span><span style=";font-family:SimSun;line-height:200%;color:#231F20;font-size:21px">即</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">经过改造</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">的</span><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro">痘苗安卡拉</span></span></span><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro">（</span></span></span><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro;line-height: 200%;color: #231F20;font-size: 21px">Ankara</span></span><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro">）</span></span></span><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro">病毒</span></span></span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px"><span style="font-family:ScalaLancetPro">，表达</span>RSV表面抗原(F和G)和内</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">部</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px"><span style="font-family:ScalaLancetPro">蛋白</span>(M2和N)</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">。</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">在第一</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">期临床</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">试验中，年轻人和老年人的细胞和体液免疫反应相似</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">。</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px"><span style="font-family:ScalaLancetPro">一项</span>2a期人</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">体</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px"><span style="font-family:ScalaLancetPro">挑战研究</span>(n=61)结果显示</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">，</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px"><span style="font-family:ScalaLancetPro">有症状的</span>RSV感染减少79%，病毒载量</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">也有</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">减少</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">。</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px"><span style="font-family:ScalaLancetPro">在老年人中进行的</span>2期</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">临床</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">试验显示抗体反应升高</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">维持了</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">6个月，在</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">第</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">12个月时</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">还</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">可以安全地</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">通过加强接种增强</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">抗体反应。在</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">通过</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">2期</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">临床</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">试验选</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">定</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px"><span style="font-family:ScalaLancetPro">了剂量后，正在进行</span>3期试验的准备工作</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">。</span></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">针对两种不同的目标人群开发</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">的</span><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro;line-height: 200%;color: #FF0000;font-size: 21px"><span style="font-family:ScalaLancetPro">重组载体</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro;line-height: 200%;color: #FF0000;font-size: 21px"><span style="font-family:ScalaLancetPro">疫苗</span>Ad26.RSV.pre-F</span></span></strong><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">使用</span><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro">腺病毒载体</span></span></span></strong><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">，正在进行儿童的</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">2期</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">临床</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">试验</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">（登记号</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">CT03303625和NCT03606512)和老年人</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">的</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">3期</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">临床</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">试验</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">（</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">NCT04908683)。</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">该候选疫苗</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">表达</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">具有</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">pre-F构象的RSV F蛋白</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">。</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px"><span style="font-family:ScalaLancetPro">与之前含有</span>RSV post-F蛋白的候选疫苗(Ad26.RSV.FA2)相比，该候选疫苗的免疫原性有所提高。在新生小鼠中，</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">该</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px"><span style="font-family:ScalaLancetPro">候选疫苗对</span>Th1偏向</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">性</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">反应细胞表现出偏向</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">性</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px"><span style="font-family:ScalaLancetPro">反应。在对</span>60-81岁的成人进行的首次人体研究中，</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">证明</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">免疫</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">接种</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">后至少</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">有</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px"><span style="font-family:ScalaLancetPro">持续</span>2年的体液和细胞免疫反应</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">。</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px"><span style="font-family:ScalaLancetPro">在</span>RSV疫苗</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">的</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">第一个人体</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">挑战</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">研究中</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">已</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">获得了概念证明</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">。</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px"><span style="font-family:ScalaLancetPro">在</span>CYPRESS概念验证研究的主要疗效结果中，</span><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro;line-height: 200%;color: #231F20;font-size: 21px">Ad26.RSV.pre-F</span></span></strong><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px"><span style="font-family:ScalaLancetPro">在第一个</span>RSV季节在老年人群中</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">针</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px"><span style="font-family:ScalaLancetPro">对</span>RSV </span><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro;line-height: 200%;color: #231F20;font-size: 21px">LRTI</span></span><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro;line-height: 200%;color: #231F20;font-size: 21px"><span style="font-family:ScalaLancetPro">（下呼吸道感染）</span></span></span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">显示</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">出有</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">80% (95% CI 52 - 93)的疗效。</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">已证明</span><strong><span style="text-decoration:underline;"><span style="font-family: ScalaLancetPro;line-height: 200%;color: #231F20;font-size: 21px">Ad26.RSV.pre-F</span></span></strong><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">是安全的，耐受性良好，对有或没有危险因素</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">的</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">65岁</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">或</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">以上老年人有效</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">，有效率分别为</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">68% [-27 - 95]</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">和</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px"> 85%[50 - 97]。</span></p><p style="line-height: 200%">　　　<span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px"><span style="font-family:ScalaLancetPro">此外，在</span>2期临床试验中，</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">该</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">RSV疫苗与季节性流感疫苗在老年人中共同接种时没有干扰作用，而且该候选疫苗被证明具有可接受的安全性，尽管与流感疫苗相比显示出更高的反应原性。2019年，该候选</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">疫苗</span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px">被美国食品和药物管理局授予突破性疗法称号。</span></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:SimSun">随后，代号为</span><span style="font-family:Calibri">EVERGREEN</span><span style="font-family:SimSun">的</span><span style="font-family:Calibri">3</span><span style="font-family:SimSun">期临床试验于</span><span style="font-family:Calibri">2021</span><span style="font-family:SimSun">年</span><span style="font-family:Calibri">7</span><span style="font-family:SimSun">月</span><span style="font-family:Calibri">21</span><span style="font-family:SimSun">日启动，将在两个</span><span style="font-family:Calibri">RSV</span><span style="font-family:SimSun">季节对</span><span style="font-family:Calibri">23000</span><span style="font-family:SimSun">名</span><span style="font-family:Calibri">60</span><span style="font-family:SimSun">岁及以上的成年人进行疗效评估。对于儿科候选疫苗，在</span><span style="font-family:Calibri">12-24</span><span style="font-family:SimSun">个月血清阳性婴儿中的</span><span style="font-family:Calibri">1/2b</span><span style="font-family:SimSun">期试验显示</span></span><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px"> </span><strong><span style="font-family: ScalaLancetPro;line-height: 200%;color: #231F20;font-size: 21px">Ad26.RSV.Pre-F</span></strong><span style=";font-family:ScalaLancetPro;line-height:200%;color:#231F20;font-size:21px"> </span><span style=";font-family:SimSun;line-height:200%;font-size:21px">具有良好的耐受性，并能引起体液和细胞免疫反应。</span></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style=";font-family:SimSun;line-height:200%;font-size:21px">值得注意的是，一种</span><strong><span style="text-decoration:underline;"><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">SARS-CoV-2</span><span style="font-family:SimSun">（新冠病毒</span></span></span></strong><span style=";font-family:SimSun;line-height:200%;font-size:21px">）腺病毒载体候选疫苗暴露了腺病毒载体疫苗的新的</span><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px">安全性问题</span></strong><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:SimSun">，包括至少两种</span><span style="font-family:Calibri">COVID-19</span><span style="font-family:SimSun">腺病毒载体疫苗观察到的疫苗诱导的</span></span><span style="text-decoration:underline;"><span style="font-family: SimSun;line-height: 200%;font-size: 21px">免疫性血栓性血小板减少</span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px">。</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 21px">（未完待续）</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 24px">参考文献：</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><em><span style="font-family: Shaker2Lancet-Italic;color: #006F3C;letter-spacing: 0;font-size: 20px">Natalie I Mazur,</span></em><em>　</em><em><span style="font-family: Shaker2Lancet-Italic;color: #006F3C;letter-spacing: 0;font-size: 20px">et al., </span></em><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 20px">Respiratory syncytial virus prevention within reach:</span></strong><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 20px"> the vaccine and monoclonal antibody landscape, </span></strong><em><span style="font-family: Shaker2Lancet-Bold;color: #FF0000;letter-spacing: 0;font-size: 20px">Lancet Infect Dis</span></em><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 20px"><span style="font-family:Shaker2Lancet-Bold">，</span> Published online August 8, 2022， </span></strong><span style="font-family: Tahoma;color: #505050;letter-spacing: 0;font-size: 20px">DOI: </span><a href="https://doi.org/10.1016/S1473-3099(22)00291-2" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 20px">https://doi.org/10.1016/S1473-3099(22)00291-2</span></a><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 20px">，</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00291-2/fulltext" target="_blank"><span style="text-decoration:underline;"><span style="font-family: Shaker2Lancet-Bold;color: #6666CC;letter-spacing: 0;font-size: 20px">https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00291-2/fulltext</span></span></a><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 20px">.</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 24px">相关博文：</span></strong><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1350903" target="_blank"></a></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1350903" target="_blank"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=956043" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（１）</span></span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 20px"> 2022-08-12</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1350986" target="_blank"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=956041" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>2）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-13</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1351276" target="_blank"></a><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=956040" title alt="image.png" referrerpolicy="no-referrer"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1351276" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>3）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-15</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1351490" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>4）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-17</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1351871" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>5）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-20</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1352158" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>6）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-22</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1352448" target="_blank"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=956038" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>7）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-24</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1352713" target="_blank"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=956036" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>8）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-26</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=956034" title alt="image.png" referrerpolicy="no-referrer"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1352981" target="_blank"><span style="text-decoration:underline;"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>9）</span></span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-28</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1353081" target="_blank"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=956031" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>10）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-29</span></p><p style="line-height: 200%;"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1353361" target="_blank"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=956030" title alt="image.png" referrerpolicy="no-referrer"><strong><span style="font-family: Tahoma;line-height: 200%;color: #6666CC;letter-spacing: 0;font-size: 19px;background: #FFFFFF"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>11）</span></strong></a><span style="font-family: Tahoma;line-height: 200%;color: #666666;letter-spacing: 0;font-size: 19px;background: #FFFFFF"> 2022-08-31</span></p>                    <br><br>
                                        <label style="font-size:13px; color:#850f0f">转载本文请联系原作者获取授权，同时请注明本文来自严家新科学网博客。<br>链接地址：</label><a href="https://blog.sciencenet.cn/blog-347754-1353798.html" target="_blank" style="font-size:13px; color:#850f0f">https://blog.sciencenet.cn/blog-347754-1353798.html </a>
  <br><br>上一篇：<a href="http://blog.sciencenet.cn/blog-347754-1353641.html" target="_black">猴痘病毒能通过受污染物体间接传播吗？</a><br>                    <!--大赛结束-->
                                        
  
</div>
            